Indicators

Markets:

News

Latest News about Weight Loss

Recent news which mentions Weight Loss

< Previous 1 2 3 4 5 6 Next >

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

November 21, 2024

Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?

November 05, 2024

Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains

October 29, 2024

Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments

September 25, 2024

Lose Weight With Novo Nordisk Drugs, Gain Money With Stock

September 25, 2024

EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'

September 25, 2024

Novo Nordisk To Consider Ways For Patients To Affordably Access Weight Loss Drugs Ozempic, Wegovy, Says CEO

September 24, 2024

Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints

September 20, 2024

European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure

September 20, 2024

Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan

September 11, 2024

September Volatility Returns As Labor Cools, Bets On Large Fed Rate Cut Intensify, Semiconductors Plunge: This Week In The Markets

September 06, 2024

Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern

September 05, 2024

Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst

August 22, 2024

Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle

August 21, 2024

Weight-Loss Giant Novo Nordisk Tumbles To 200-Day Average Support: 'Weakness Could Be Buying Opportunity,' Analyst Says

August 07, 2024

What's Going On With HIMS Shares Today?

August 01, 2024

Inflation Drop Fuels Rate Cut Speculation, Investors Shift To Sector Laggards, Russell 2000 Surges Over 3.6%: This Week In The Markets

July 12, 2024

Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows

July 09, 2024

EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO

July 07, 2024

How the Workout Guru resource helps those who want to live a healthier lifestyle

July 02, 2024

Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand

June 27, 2024

Hims & Hers Health Stock Is Sliding Thursday: What's Going On?

June 27, 2024

Wegovy, Ozempic Maker Novo Nordisk To Invest $4.1B In US Manufacturing, Doubling Plant Size To Meet Surging Demand For Weight Loss Drugs

June 25, 2024

Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments

June 21, 2024

JPMorgan's $500M Venture Capital Fund Bets Big On Weight-Loss Drugs: 'They're All The Rage'

June 13, 2024

Humans Clamor For Weight Loss Drugs, But The Next Users Could Be... Pets?

June 12, 2024

ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential

June 07, 2024

Chinese Generic Ozempic, Wegovy Versions Could Put Novo Nordisk At The Risk Of Stiff Competition In Key Market

June 05, 2024

Can Krispy Kreme Overcome Ozempic Fears And Become The Next Chipotle?

May 31, 2024

New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk

May 30, 2024

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.